F. Gilbert Bickel
Directeur/Membre du Conseil chez St. Louis Regional Chamber & Growth Association
Profil
F.
Gilbert Bickel is currently a Director at St. Louis Regional Chamber & Growth Association.
Prior to this, he was a Director at Sequoia Vaccines, Inc.
Postes actifs de F. Gilbert Bickel
| Sociétés | Poste | Début |
|---|---|---|
St. Louis Regional Chamber & Growth Association
 St. Louis Regional Chamber & Growth Association Miscellaneous Commercial ServicesCommercial Services St. Louis Regional Chamber & Growth Association operates as a non-profit organization, which engages in economic development business and public policy. The company was founded in 1836 and is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | - |
Anciens postes connus de F. Gilbert Bickel
| Sociétés | Poste | Fin |
|---|---|---|
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
St. Louis Regional Chamber & Growth Association
St. Louis Regional Chamber & Growth Association Miscellaneous Commercial ServicesCommercial Services St. Louis Regional Chamber & Growth Association operates as a non-profit organization, which engages in economic development business and public policy. The company was founded in 1836 and is headquartered in St. Louis, MO. | Commercial Services |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Health Technology |
